American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

January 13, 2016

Newsletter Sponsor

Claim your Complimentary Subscription
Sign Up Now!
Stay up-to-date with information on industry trends, regulatory movements, and technological advances in drug delivery, bioprocessing, formulation development, and more. Subscribe to American Pharmaceutical Review ® magazine today.

	Industry News

Survey: 91% of U.S. Corporate Leaders Say Their Organizations are Planning on Making an Acquisition In 2016

West Announces New Organizational Structure

Perrigo Recalls Children's Guaifenesin Liquid Due to a Potential Defect with the Dosage Cup

Shire to Combine with Baxalta in $32 Billion Deal

Adimab Announces Technology Transfer Agreement with Merck

Execs Aim to Cut Costs to Fuel Growth, But Majority Struggle to Sustain the Cost Reduction Benefits

	Featured Articles

Part III, Endotoxin Test Concerns of Biologics: LER From a Broad Biologics Test Perspective Part III, Endotoxin Test Concerns of Biologics: LER From a Broad Biologics Test Perspective Recent conferences have demonstrated the polarizing nature of the Low Endotoxin Recovery debate, ... read more »

Topical Drug Delivery Considerations for Biologics Topical Drug Delivery Considerations for Biologics The demand for biologics and biosimilars is estimated to grow to more than $100 billion in 2015, ... read more »

	Featured Video

Exemplar Plus LS High Performance Smart Spectrometer
Exemplar Plus LS High Performance Smart Spectrometer
This product spotlight features our Exemplar Plus LS high performance smart spectrometer. It utilizes an aberration corrected concave holographic ... read more »

Interview with Shimadzu Corporation at AAPS 2015
Interview with Shimadzu Corporation at AAPS 2015
In this video filmed at AAPS 2015, Mike Auerbach speaks with Brian Domanski, Shimadzu’s Product Manager for HPLC, about Shimadzu’s newest technology. ... read more »

	Featured Whitepaper

Development of orally disintegrating tablets comprising controlled-release multiparticulate beads
Development of orally disintegrating tablets comprising controlled-release multiparticulate beads
Melperone is an atypical antipsychotic agent that has shown a wide spectrum of neuroleptic properties, particularly effective in the treatment of senile dementia and Parkinson’s-associated psychosis, ... read more »

Comparative Human In-Vivo Study of an Immediate Release Tablet Over-Encapsulated by Gelatin and Hydroxypropyl Methyl Cellulose Capsules - Impact Of Dissolution Rate on Bioequivalence
Comparative Human In-Vivo Study of an Immediate Release Tablet Over-Encapsulated by Gelatin and Hydroxypropyl Methyl Cellulose Capsules - Impact Of Dissolution Rate on Bioequivalence
Rapid and consistent in-vivo drug dissolution is critical for drug absorption. In-vitro dissolution tests are used to predict in-vivo disintegration and dissolution properties of drug products. The in... read more »

	Events


13th Annual Controlled Release		4th Annual Corporate Compliance & Transparency in Pharmaceutical Industry

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA